tifluadom has been researched along with 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one in 1 studies
Studies (tifluadom) | Trials (tifluadom) | Recent Studies (post-2010) (tifluadom) | Studies (2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one) | Trials (2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one) | Recent Studies (post-2010) (2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one) |
---|---|---|---|---|---|
78 | 0 | 0 | 184 | 0 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barber, DJ; Cooper, SJ; Jackson, A; Moores, WR | 1 |
1 other study(ies) available for tifluadom and 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one
Article | Year |
---|---|
Effects of tifluadom on food consumption compared with chlordiazepoxide and kappa agonists in the rat.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzodiazepines; Benzodiazepinones; Benzomorphans; Chlordiazepoxide; Convulsants; Cyclazocine; Drug Interactions; Eating; Ethylketocyclazocine; Flumazenil; Male; Naloxone; Pyrazoles; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, kappa | 1985 |